How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

That one is tirzepatide ... There's another company called Structure Therapeutics that is also working on a non peptide small molecule, but there are other ones coming along all the time.

A real-world study of over 4,000 US patients without type 2 diabetes found that those who persisted with Tirzepatide for at ...

Tryptamine psychoactive substances, such as α-methyltryptamine (AMT), are monoamine alkaloids characterized by an indole ring ...

A recent study published in Diabetes Technology & Therapeutics has demonstrated that off-label use of semaglutide and tirzepatide leads to significant reductions in glycated haemoglobin (HbA1c ...

Tirzepatide stands out due to its dual-action mechanism as a GIP and GLP-1 receptor agonist. Comprising a molecular weight of 4873.5, its intricate formula C227H352N48O70 showcases its advanced design ...

1 This denial keeps in place the FDA’s declaratory order determining that the shortage of diabetes and weight-loss tirzepatide products has been resolved and phases out compounded tirzepatide ...

The appeal is the latest move in the compounders’ battle to continue making copies of tirzepatide and other GLP-1s, including semaglutide. The FDA declared an end to the 2-year-old tirzepatide ...

By removing both semaglutide and tirzepatide (the actives in Wegovy and Zepbound, respectively) from its drug shortage list, the agency is cutting off the primary legal route that allows ...

The drug builds on the success of earlier treatments such as GLP-1 receptor agonists such as liraglutide and semaglutide and the dual GIP/GLP-1 agonist tirzepatide. Preclinical studies suggested that ...